Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

BCDA

BioCardia, Inc.

California-based BioCardia Inc., a clinical-stage regenerative medicine firm, is in the development stage of creating cellular and cell-derived treatments for pulmonary and cardiovascular diseases....

BioCardia, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

KURA

Kura Oncology

Kura Oncology, Inc. - A Key Player in the Cancer Treatment Industry Kura Oncology, Inc. is a prominent clinical-stage biopharmaceutical company, primarily focused on developing innovative therapie...

Kura Oncology Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

RSH

Respiri Limited

Respiri Limited is an innovative e-health software-as-a-service (SaaS) company that specializes in the research, development, and commercialization of medical devices. With locations in both Austra...

Respiri Limited Annual Report 2023

Healthcare ASX 1-10

EMD

Emyria

Legg Mason Partners Fund Advisor, LLC has launched and currently manages the open-ended fixed-income mutual fund, Western Asset Emerging Markets Debt Fund Inc. The fund operates with co-management ...

Emyria Annual Report 2023

Healthcare Healthcare Information Services ASX 11-50

AXLA

Axcella Health

Cambridge-based biotech firm, Axcella Health Inc., has been making waves in the clinical stage biotechnology sector in the U.S. The company's unique approach to treating complex diseases and enhanc...

Axcella Health Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

APLT

Applied Therapeutics, Inc.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, based in New York, is blazing a trail in rare disease and diabetic complications research in the United States. The company i...

Applied Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

TLC

Taiwan Liposome Company, Ltd.

Taiwan Liposome Company (TLC) is a clinical-stage pharmaceutical company that specializes in developing and commercializing nanomedicines that use lipid-assembled drug delivery platforms combined w...

Taiwan Liposome Company, Ltd. Annual Report 2019

Healthcare Biotechnology NASDAQ 51-200

HHI

Health House International

Health House International Limited is a publicly-listed medicinal cannabis distributor that completed a reverse takeover after raising $3.5 million in March 2021. The company was founded to take ad...

Health House International Annual Report 2021

Healthcare ASX 11-50

CDX

Cloud DX

CardieX Limited is an Australia-based medical device company that focuses on cardiovascular health management. Its products are marketed worldwide and include technologies that are used to measure ...

Cloud DX Annual Report 2023

Healthcare ASX 11-50

IMMP

Immutep Limited

Immutep Limited, a Sydney-based biotechnology company, is advancing cutting-edge research and development efforts in the pharmaceutical industry. With a focus on developing immunotherapeutic produc...

Immutep Limited Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

MBX

Microbix Biosystems Inc.

Microbix Biosystems Inc. is a Canadian company that specializes in the development of biological products and technologies. The company's primary focus is the production of infectious disease antig...

Microbix Biosystems Inc. Annual Report 2023

Healthcare Biotechnology TSX 51-200

IMMU

Mendus

Immunomedics is a biopharmaceutical company that specializes in the development and marketing of monoclonal, antibody-based products for cancer, autoimmune, and other serious diseases. The company ...

Mendus Annual Report 2018

Healthcare Biotechnology NASDAQ 51-200

PSNL

Personalis

Personalis, Inc. is making strides in the cancer genomics industry, providing sequencing and data analysis services globally to support the development of cancer therapies and large-scale genetic r...

Personalis Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

ENTX

Entera Bio Ltd.

Entera Bio Ltd., a Jerusalem-based clinical-stage biopharmaceutical company, is making strides in the development and commercialization of orally delivered large molecule therapeutics for unmet med...

Entera Bio Ltd. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

CNCE

Concert Pharmaceuticals Inc

Concert Pharmaceuticals is a biopharmaceutical company focused on developing small molecule drugs for a variety of medical conditions, including central nervous system disorders, genetic diseases, ...

Concert Pharmaceuticals Inc Annual Report 2020

Healthcare Biotechnology NASDAQ 51-200